Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Top Cited Papers
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 131 (3), 463-475
- https://doi.org/10.1016/j.cell.2007.08.038
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth FactorThe American Journal of Pathology, 2006
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in miceBlood, 2006
- Placenta growth factor is over-expressed and has prognostic value in human breast cancerEuropean Journal Of Cancer, 2005
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell, 2005
- The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancerCancer Letters, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Altered tumor vessel maturation and proliferation in placenta growth factor‐producing tumors: Potential relationship to post‐therapy tumor angiogenesis and recurrenceInternational Journal of Cancer, 2003
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities: IMPLICATIONS FOR A FUNCTIONAL ROLE OF PLACENTA GROWTH FACTOR IN MONOCYTE ACTIVATION AND CHEMOTAXISPublished by Elsevier BV ,1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996